R-CHOP benefits older mantle-cell lymphoma patients
(HealthDay) -- In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintenance ...
Cancer
Aug 09, 2012 |
not rated yet |
0
Researchers test new drug for patients with neuroendocrine tumors
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma ...
Cancer
Aug 06, 2012 |
not rated yet |
0
Scientists identify likely predictors of hepatitis C severity: viral evolution and host protein levels
(Medical Xpress) -- Scientists at the National Institutes of Health have identified several factors in people infected with the hepatitis C virus that may predict whether the unusually rapid progression of disease from initial ...
Diseases, Conditions, Syndromes
Jul 23, 2012 |
5 / 5 (1) |
0
|
Afinitor approved for advanced breast cancer
(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food ...
Medications
Jul 23, 2012 |
not rated yet |
0
HIV-2 infection inhibits HIV-1 disease progression
(HealthDay) -- While many people don't know it, there's more than one kind of AIDS virus. Besides the HIV-1 strain that's common throughout the world, a type known as HIV-2 is found in some parts of Africa. ...
HIV & AIDS
Jul 19, 2012 |
5 / 5 (2) |
0
|
Penn expert addresses ethical implications of testing for Alzheimer's disease risk
Diagnostic tests are increasingly capable of identifying plaques and tangles present in Alzheimer's disease, yet the disease remains untreatable. Questions remain about how these tests can be used in research studies examining ...
Alzheimer's disease & dementia
Jul 17, 2012 |
not rated yet |
0
Two proteins offer a 'clearer' way to treat Huntington's disease
In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critic ...
Neuroscience
Jul 11, 2012 |
4.8 / 5 (4) |
0
|
TGen method isolates biospecimens for treatment of kidney disease
Researchers at the Translational Genomics Research Institute (TGen) have developed a method of isolating biospecimens that could lead to a less costly, less invasive and more accurate way of diagnosing chronic kidney disease, ...
Diseases, Conditions, Syndromes
Jul 11, 2012 |
not rated yet |
0
Metastatic breast cancer: Bevacizumab slows progression, but has no impact on survival
The cancer drug bevacizumab (Avastin) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed ...
Cancer
Jul 10, 2012 |
not rated yet |
0
Scientists discover mechanism that controls obesity, atherosclerosis and potentially cancer
Scientists from the Institute of Molecular and Cell Biology (IMCB) have discovered a new signalling pathway that controls both obesity and atherosclerosis. The team demonstrated, for the first time, that mice deficient in ...
Medical research
Jul 03, 2012 |
5 / 5 (3) |
0
Study finds significantly higher rate of untreated kidney failure among older adults
In a study that included nearly 2 millions adults in Canada, the rate of progression to untreated kidney failure was considerably higher among older adults, compared to younger individuals, according to a study in the June ...
Diseases, Conditions, Syndromes
Jun 19, 2012 |
not rated yet |
0
Active ingredient of cannabis has no effect on the progression of multiple sclerosis
The first large non-commercial study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS) shows that there ...
Neuroscience
Jun 15, 2012 |
not rated yet |
0
Changes in tumor size by RECIST correlate with survival
(HealthDay) -- RECIST categories used to quantify tumor changes during exposure to anticancer therapies correlate well with overall survival (OS) but reflect a more linear continuum without clear inflection ...
Cancer
Jun 13, 2012 |
not rated yet |
0
Study examines telephone intervention in glaucoma treatment adherence
A telephone intervention trial was associated with improvement in glaucoma medication adherence in both the treatment group and the control group but, when the two groups were compared, interactive telephone calls and tailored ...
Ophthalmology
Jun 11, 2012 |
not rated yet |
0
Sick from your stomach: Bacterial changes may trigger diseases like rheumatoid arthritis
The billions of bugs in our guts have a newfound role: regulating the immune system and related autoimmune diseases such as rheumatoid arthritis, according to researchers at Mayo Clinic and the University of Illinois at Urbana-Champaign.
Inflammatory disorders
Jun 11, 2012 |
5 / 5 (3) |
0
|
